Intellia Therapeutics, Inc. Income Statement
NTLA / Health Care|12 years of annual SEC 10-K data (FY2014-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 12 fiscal years. All figures from audited SEC 10-K filings.
Intellia Therapeutics, Inc. reported $68M in revenue and $413M in net loss for FY2025. Revenue has grown at a 17.0% compound annual rate over the past 9 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $67.7M | $57.9M | $36.3M | $52.1M | $33.1M | $58.0M | $43.1M | $30.4M | $26.1M | $16.5M | - | - |
| Cost of Revenue | - | - | - | - | $0 | $0 | $0 | $0 | - | - | - | - |
| SG&A Expense | $119.8M | $125.8M | $116.5M | $90.3M | $71.1M | $44.2M | $41.1M | $32.2M | $28.0M | $16.8M | $8.3M | $2.4M |
| R&D Expense | $388.9M | $466.3M | $435.1M | $420.0M | $229.8M | $150.4M | $108.4M | $89.1M | $67.6M | $31.8M | $11.2M | $1.1M |
| Operating Income | -$441.0M | -$534.3M | -$515.3M | -$458.2M | -$267.9M | -$136.6M | -$106.4M | -$90.9M | -$69.6M | -$32.2M | -$13.4M | -$9.5M |
| Income Tax | $0 | - | - | - | - | - | - | - | - | $0 | -$1.0M | - |
| Net Income | -$412.7M | -$519.0M | -$481.2M | -$474.2M | -$267.9M | -$134.2M | -$474.2M | -$85.3M | -$67.5M | -$31.6M | -$12.4M | -$9.5M |
| EPS (Basic) | -$5.42 | -$6.16 | -$3.78 | -$2.40 | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$5.42 | -$6.16 | -$3.78 | -$2.40 | -$2.11 | -$1.98 | -$1.88 | -$1.42 | - | - | - | - |
| Shares Outstanding | 102.0M | 93.0M | 87.1M | 74.5M | 66.2M | 50.2M | 45.2M | 42.4M | 36.0M | 22.2M | 243.0K | 826.0K |
| Operating Margin | -651.7% | -923.1% | -1420.5% | -879.0% | -810.4% | -235.5% | -246.8% | -298.6% | - | - | - | - |
| Profit Margin | -609.8% | -896.8% | -1326.5% | -909.8% | -810.5% | -231.5% | -1100.1% | -280.4% | - | -192.0% | - | - |